DE69615984T2 - Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen - Google Patents
Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von MetastasenInfo
- Publication number
- DE69615984T2 DE69615984T2 DE69615984T DE69615984T DE69615984T2 DE 69615984 T2 DE69615984 T2 DE 69615984T2 DE 69615984 T DE69615984 T DE 69615984T DE 69615984 T DE69615984 T DE 69615984T DE 69615984 T2 DE69615984 T2 DE 69615984T2
- Authority
- DE
- Germany
- Prior art keywords
- ursolic acid
- medicament
- manufacture
- metastases
- suppressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7323710A JP3041232B2 (ja) | 1995-11-16 | 1995-11-16 | 癌転移抑制剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69615984D1 DE69615984D1 (de) | 2001-11-22 |
DE69615984T2 true DE69615984T2 (de) | 2002-07-04 |
Family
ID=18157744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69615984T Expired - Lifetime DE69615984T2 (de) | 1995-11-16 | 1996-11-15 | Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen |
Country Status (7)
Country | Link |
---|---|
US (1) | US5985924A (de) |
EP (1) | EP0774255B1 (de) |
JP (1) | JP3041232B2 (de) |
KR (1) | KR100424503B1 (de) |
CN (1) | CN1073843C (de) |
AT (1) | ATE206914T1 (de) |
DE (1) | DE69615984T2 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775686B1 (fr) * | 1998-03-09 | 2006-07-28 | Pascal Commenil | Exploitation industrielle et commerciale des lipides cuticulaires de la baie de raisin en pharmacologie et cosmetologie |
DE60102402T2 (de) * | 2000-02-10 | 2005-03-10 | Loders Croklaan B.V. | Fettmischungen mit Kristallmodifikatoren |
AU2001283038A1 (en) * | 2000-07-31 | 2002-02-13 | University Of Virginia Patent Foundation | Inhibitors of dna polymerase sigma |
EP1321145A4 (de) * | 2000-07-31 | 2006-03-22 | Nisshin Oillio Ltd | Antitumorwirkstoffe |
JP2004518647A (ja) * | 2000-12-15 | 2004-06-24 | ナチュラルエンド テック カンパニー リミテッド | インシュリン様成長因子−1の分泌誘導用薬剤学的組成物および食品組成物 |
US6979470B2 (en) * | 2001-07-17 | 2005-12-27 | Metaproteomics, Llc | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US20040029906A1 (en) * | 2001-07-31 | 2004-02-12 | Michael Christman | Inhibitors of dna polymerase sigma |
JP2005527613A (ja) * | 2002-05-24 | 2005-09-15 | グレイストーン メディカル グループ、インコーポレイテッド | 抗癌製剤 |
CN1243538C (zh) * | 2002-11-21 | 2006-03-01 | 武汉利元亨药物技术有限公司 | 熊果酸豆磷脂纳米粒冻干粉针及制备方法 |
WO2005034958A1 (en) | 2003-10-10 | 2005-04-21 | Sk Chemicals, Co., Ltd. | Triterpene compounds which are effective on improvement of brain function |
JP4810642B2 (ja) * | 2004-11-30 | 2011-11-09 | 秋田県 | 癌転移抑制用トリテルペン誘導体及び該トリテルペン誘導体を用いた癌転移抑制用組成物 |
US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
WO2014022772A1 (en) | 2012-08-03 | 2014-02-06 | University Of Iowa Research Foundation | Tomatidine, analogs thereof, compositions comprising same, and uses for same |
JP5808797B2 (ja) * | 2010-05-20 | 2015-11-10 | ユニバーシティ オブ アイオワ リサーチ ファウンデーション | 筋萎縮を阻害するための方法 |
AU2012268036B2 (en) | 2011-06-06 | 2017-04-06 | THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS | Methods of inhibiting muscle atrophy |
EP3409280B1 (de) * | 2012-07-05 | 2021-04-14 | Nutramax Laboratories, Inc. | Zusammensetzungen mit einem sulforaphan sowie mariendistelextrakt oder pulver |
JP6211380B2 (ja) * | 2012-10-17 | 2017-10-11 | 丸善製薬株式会社 | Tie2活性化剤、血管新生抑制剤、血管の成熟化剤、血管の正常化剤、及び血管の安定化剤 |
KR102155125B1 (ko) * | 2015-07-17 | 2020-09-11 | 경희대학교 산학협력단 | 악성 중피종 예방 또는 치료용 조성물 |
CN105534991A (zh) * | 2015-12-24 | 2016-05-04 | 上海交通大学医学院 | 五环三萜类化合物在制备usp7抑制剂中的应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE707409A (de) * | 1967-12-01 | 1968-04-16 | ||
JPS6439973A (en) * | 1987-08-06 | 1989-02-10 | Taiyo Kagaku Kk | Drink composition |
JPH03287530A (ja) * | 1990-03-31 | 1991-12-18 | Snow Brand Milk Prod Co Ltd | 免疫抑制剤 |
US5519008A (en) * | 1992-09-10 | 1996-05-21 | Glycomed Incorporated | Derivatives of triterpenoid acids as inhibitors of cell-adhesion molecules ELAM-1 (E-selectin) and LECAM-1 (L-selectin) |
JPH0748250A (ja) * | 1993-06-04 | 1995-02-21 | Sekisui Chem Co Ltd | 眠気防止用テープ |
US5643884A (en) * | 1993-08-09 | 1997-07-01 | Glycomed Incorporated | Lupane triterpenoid derivatives |
-
1995
- 1995-11-16 JP JP7323710A patent/JP3041232B2/ja not_active Expired - Fee Related
-
1996
- 1996-11-15 AT AT96308340T patent/ATE206914T1/de not_active IP Right Cessation
- 1996-11-15 DE DE69615984T patent/DE69615984T2/de not_active Expired - Lifetime
- 1996-11-15 EP EP96308340A patent/EP0774255B1/de not_active Expired - Lifetime
- 1996-11-15 US US08/749,403 patent/US5985924A/en not_active Expired - Fee Related
- 1996-11-15 KR KR1019960054598A patent/KR100424503B1/ko not_active IP Right Cessation
- 1996-11-15 CN CN96114489A patent/CN1073843C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0774255A1 (de) | 1997-05-21 |
CN1073843C (zh) | 2001-10-31 |
CN1157716A (zh) | 1997-08-27 |
JPH09143076A (ja) | 1997-06-03 |
ATE206914T1 (de) | 2001-11-15 |
DE69615984D1 (de) | 2001-11-22 |
KR100424503B1 (ko) | 2004-06-04 |
JP3041232B2 (ja) | 2000-05-15 |
EP0774255B1 (de) | 2001-10-17 |
KR970025615A (ko) | 1997-06-24 |
US5985924A (en) | 1999-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69615984T2 (de) | Verwendung von Ursolsäure zur Herstellung eines Arzneimittels zur Unterdrückung von Metastasen | |
KR900700089A (ko) | 전신성 피부 투과적 투여를 위한 약학적 조성물 | |
ATE73331T1 (de) | Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus. | |
DE69331409T2 (de) | Oral 1alpha-hydroxyprevitamin d | |
ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
DE3855113T2 (de) | Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht | |
DE68912459D1 (de) | Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten. | |
ATE99172T1 (de) | Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung. | |
DE69522511D1 (de) | Spirooxathiolan-quinuclidin-Derivat zur Behandlung von Xerostomie | |
DE69428325D1 (de) | Verwendung von 2-phenyl-3-aroylbenzothiophen Derivaten zur Herstellung eines Medikaments zur Hemmung der Angiogenese und angiogene Krankheiten | |
DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
DE3850154D1 (de) | Verwendung von Gepiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung atypischer Depression. | |
KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
DE68917937T2 (de) | Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung. | |
EP0647616A4 (de) | Zink-tranexamat derivat. | |
ES2052000T3 (es) | Procedimiento para preparar composiciones farmaceuticas que contienen pentamidina. | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
ATE181503T1 (de) | Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution | |
KR880004810A (ko) | 소화성 궤양 치료제 | |
DE59409413D1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
DE68910010D1 (de) | Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin. | |
ATE190628T1 (de) | Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung | |
HUP0103864A2 (hu) | 3-(1H-4-Imidazolimetil)-indan-5-ol alkalmazása intraspinálisan beadható gyógyszerkészítmények előállítására |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |